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The present report documents the occurrence of lupus nephropathy as the sole initial
manifestation of systemic lupus erythematosus (SLE). Despite the absence of initial systemic
signs characteristic of SLE, the diagnosis was confirmed on the basis of the renal histopatho-
logic features and serological studies. Subsequent follow-up demonstrated systemic features of
the disease in each of the four patients.
The report shows that the diagnostic criteria for SLE proposed by the American Rheumatol-
ogy Association may not be fulfilled at the time of the initial evaluation in all cases, and that
some patients may exhibit signs attributable to primary renal disease. These data emphasize the
importance of careful assessment of the pattern of glomerular ultrastructural changes and
usefulness of appropriate serological studies.
INTRODUCTION
Clinical recognition of systemic lupus erythematosus (SLE) in individual patients
is often complicated by the wide spectrum of clinical manifestations which may
simulate other disease entities. Conversely, the systemic features of SLE may be
masked, at least initially, when clinical signs are restricted to a single organ system.
To establish a uniform means to identify and classify patients with SLE, the
American Rheumatology Association (ARA) published diagnostic criteria in 1971
which included 14 criteria, eight of which were clinical and six were laboratory [1].
The presence of four or more criteria in an individual patient was construed to be
compatible with the diagnosis of SLE.
Despite the usefulness of the criteria proposed by the ARA, occasional patients
with SLE have been reported in whom these criteria were not fulfilled at the time of
initial clinical presentation [2,3]. Since SLE exhibits a variable natural course and the
criteria proposed by the ARA were derived from patients attending rheumatology
clinics, it is not surprising that exceptions to the classification occur.
Although previous reports have stated that lupus nephropathy may occur as the
sole presenting sign of SLE in three to six percent of cases [2,3], documentation has
not been provided to establish the existence of lupus nephropathy in the absence of
non-renal manifestations at onset of disease. Recognition of this possible clinical
variant of SLE has important clinical implications since treatment with glucocorti-
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All rights of reproduction in any form reserved.coids and/ or cytotoxic drugs may alter the renal histopathology and clinical course
of lupus nephropathy [4].
In the present report, we describe four patients with SLE in whom the initial
clinical manifestation was restricted to signs of renal disease. Although the published
criteria of the ARA for SLE were not fulfilled at the time of initial evaluation,
specific serological studies, renal histopathological features, and/or subsequent
clinical manifestations ultimately led to the recognition of SLE.
CaseI
R.B., a61-year-old woman, was ingood general health until March 1970, when she
was admitted to a community hospital complaining of a 30-pound weight loss,
nervousness, and fever. Physical examination demonstrated a temperature of
103.60F. and a diffusely enlarged thyroid gland. There was no evidence of rash or
arthritis. Laboratory evaluation included a protein-bound iodine of 10 micrograms
(normal 4-8 micrograms) and a T3 resin uptake of 45 percent. Urinalysis showed 1+
protein, 6-8 RBC and 4-6 WBC/HPF. BUN was 19 mg/dl, Hg 11.5 gm/dl, and
WBC was 3700/ml. Several LE preparations were negative. The diagnosis of
hyperthyroidism was made and the patient was begun on propylthiouracil. Within
several days, the patient developed leukopenia characterized by a white blood cell
count of 1800/ ml with 12 percent polymorphonuclear cells and 74 percent lympho-
cytes. Propylthiouracil was discontinued and methimazole was begun. Following the
change in therapy, the patient's temperature fell to normal levels and white blood cell
count rose to 4700 with 42 percent polymorphonuclear cells.
She remained asymptomatic until October 1971 when she was readmitted to the
hospital for evaluation of dependent edema of one month's duration. With the
exception of edema to the level of her knees and mild hypertension, the physical
examination was normal. The patient denied systemic manifestations including rash,
arthritis, or arthralgia. Laboratory studies showed the following: Hct 34 percent,
WBC 4800/ml, serum creatinine 1.0 mg/dl, creatinine clearance 60 ml/min, serum
albumin 2.6 gm/dl, and urinary protein 4.8 gm/day. A percutaneous renal biopsy
was performed and demonstrated a severe diffuse proliferative and focally necrotiz-
ing glomerulonephritis with acute necrotizing periarteritis by light microscopy.
Examination by electronmicroscopy showed massive subendothelial deposits and
electron-dense deposits in subepithelial and mesangial loci. Since the renal histopath-
ological features were considered to be characteristic of lupus glomerulonephritis,
serological studies were performed and showed a positive antinuclear factor (ANF)
of 1:256, and a C3 of 36 mg/dl (normal values 78-150 mg/dl).
Treatment was begun with azathioprine 100 mg/day and prednisone 10 mg/day.
Within two months of initiating treatment, the urinary protein excretion fell to less
than 300mg/day. During theensuing fouryears, she remained asymptomatic and the
levels of serum creatinine, urinary protein excretion, and C3 were within normal
limits and ANF titers were less than 1:40. Determination of DNA binding capacity
(DNA-bc) was first performed in February 1973 and was 12 percent and remained
less than 15 percent on subsequent studies (normal values < 20 percent [5]). Renal
biopsies performed in 1973 and 1975 showed a marked reduction in the intraglomeru-
lar inflammatory reaction, complete resolution of subendothelial deposits, and
persistence ofsubepithelial and mesangial deposits. Azathioprine was discontinued in
November 1975 and prednisone was continued in a dose of 5 mg/day.
In June 1977, whileasymptomatic, the DNA-bc rose to 34 percent and C3 fell to 26
mg/dl. Urinary protein excretion was 300 mg/day. With six weeks, a macular
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erythematous rash appeared on the lower extremities and was shown to be a
leukocytoclastic angiitis by biopsy. Urinary protein excretion rose to 1.7 gm/day and
the serum creatinine was 1.1 mg/dl. A fourth renal biopsy showed an increase in
proliferation of intraglomerular cells and return ofsubendothelial deposits. Azathio-
prine 100 mg/day was reinstituted and the dose of prednisone was raised to 40
mg/day. The rash on the lower extremities resolved within one week and urinary
protein excretion returned to normal levels within four weeks. Concurrent with
clinical improvement, the C3 level rose to 90 mg/dl and DNA-bc fell to below 15
percent. The patient remained clinically stable during the ensuing 36 months on
azathioprine 100 mg/day and prednisone 10 mg/day.
Comment
The diagnosis of SLE in this patient was based on the renal histopathology, the
elevated titers of ANF, and reduced C3 level. Subsequently, the patient developed a
cutaneous vasculitis and elevated level of DNA antibodies.
Case 2
K.A., a five-year-old girl, was transferred from a community hospital for
evaluation ofproteinuria and generalized edema oftwo months' duration. Duringthe
two weeks prior to admission, she had had occasional temperatures of 101 'F. There
was no antecedent history of throat or skin infection. In addition, there was no
history of drug ingestion, rash, arthritis, or mucosal lesions. Physical examination
was notablefor atemperature of 102.40F., ascites, and peripheral edema. Laboratory
tests showed the following: Hg 8.0 gm/dl, WBC 10,400/ml, platelets 550,000,
urinalysis 4+ protein, many RBC and RBC casts, serum albumin 1.3 gm/dl, serum
creatinine of 2.6 mg/dl, ANF titer 1:512, DNA-bc 78 percent, C3 22 mg/dl, C4 20
mg/d1 (normal 21-50 mg/dl). A percutaneous renal biopsy revealed a severe
proliferative glomerulonephritis with focal necrosis and numerous cellular crescents.
Electronmicroscopy showed massive subendothelial deposits and focal mesangial
and intramembranous deposits. Several deposits had a fingerprint pattern. On
immunofluorescent staining, there was a marked deposition of IgG, IgM, IgA, C3,
C4, and fibrin in a granular pattern. Over the next five days the patient became
oliguric, the serum creatinine level rosefurther, and peritoneal dialysis was instituted.
Therapy was begun with cyclophosphamide, 25 mg/day and glucocorticoids were
administered on alternate days as 40 mg of prednisone orally and 600 mg of
methylprednisolone intravenously for a 12-day period. On the ninth day oftherapy, a
diuresis occurred. Serum creatinine levels which had risen to 3.2 mg/dl fell to 1.2
mg/dl and peritoneal dialysis was discontinued. Shewas subsequently maintained on
cyclophosphamide 25 mg/day and prednisone 40 mg/day. Over the next nine
months, renal function continued to improve and prednisone was tapered to 5
mg/day. She continues to be free of edema without salt restriction or diuretics, and
she has no signs or symptoms of SLE. Current laboratory studies include: serum
creatinine 0.5 mg/dl, 24-hour urinary protein excretion 3.0 grams, ANF titer 1:4,
DNA-bc 5 percent, C3 93 mg/dl, C4 46 mg/dl.
Comment
The diagnosis of SLE is based on the characteristic renal histopathology, elevated
titers of ANF and DNA-bc, and reduced C3 levels. Fever at the time of her initial
presentation may have represented another manifestation of SLE.
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Mr. K.F., a 53-year-old white male, was admitted to a community hospital in April
1973 complaining of left-sided scrotal pain. A urinalysis at that time revealed 1+
protein, 10-14 RBC/ HPF, 6-8 WBC/ HPF. The diagnosis of acute epididymitis was
made and antibiotic therapy was initiated with apparent resolution of symptoms. He
was readmitted two weeks later with fatigue and periorbital edema. Repeat urinalysis
showed 4+ protein, 25 RBC/HPF, 8 WBC/HPF. BUN was 20 mg/dl. On May 5,
1973, he was admitted to Yale-New Haven Hospital for a percutaneous renal biopsy.
Aside from an admission blood pressure of 160/110 mm Hg, physical examination
was normal. Laboratory studies included the following: serum creatinine 2.0 mg/dl,
creatinine clearance 32 ml/min, serum albumin 1.8 gm/dl, urinalysis 2+ protein, 5-10
RBC/HPF, 5-10 WBC/HPF, 24-hour urinary protein excretion of 5.0 gm, ANF
1:128, LE preparation +, C3 30 mg/dl. Renal biopsy showed diffuse proliferative
glomerulonephritis with focal necrosis and an accentuation ofthe glomerular lobules,
with thickening of the capillary walls. Electronmicroscopy revealed extensive depos-
its in subendothelial, mesangial, and epimembranous positions. On immunofluores-
cent staining, there was a granular deposition of C3 in capillary walls.
Because of the renal biopsyfindings and serological tests, the patient was begun on
azathioprine 100 mg/day and prednisone 30 mg/day. Approximately one month
later, he developed daily temperature elevations to 103°F. and generalized pruritus.
Azathioprine was discontinued with resolution ofsymptoms. When azathioprine was
restarted, fever recurred. The cytotoxic agent was changed to cyclophosphamide, 75
mg/day. Over the next year, C3 levels normalized, but daily protein excretion of 3.0
grams persisted. Serum creatinine decreased to 1.4 mg/dl. DNA-bc was 11 percent
when first assayed six months following presentation while the patient was on
prednisone and cyclophosphamide therapy. In September 1974, he sustained an acute
myocardial infarction and recovery was uncomplicated.
In December 1974, he underwent a second percutaneous renal biopsy which
revealed a marked decrease in glomerular hypercellularity and persistent capillary
wall thickening. Electronmicroscopy showed abundant intramembranous deposits
and areas of glomerular basement membrane rarefaction. No subendothelial or
mesangial deposits were seen. In August 1975, he was admitted for evaluation of
fever. Laboratory studies showed the following: serum creatinine 1.5 mg/dl, urinary
protein excretion less than 100 mg/day, DNA-bc 2 percent. Cyclophosphamide was
discontinued, prednisone was increased to 20 mg/day, and his fever resolved. In
November 1975, he was readmitted with dizziness. Neurological examination showed
an abnormal mental status and right-sided pyramidal symptoms. Laboratory eval-
uation included: normal brain scan and electroencephalogram, ANF 1:8, DNA-bc
0 percent, C3 94 mg/dl. The etiology of the dizziness was not clearly defined and he
was discharged without a change in medication. Aside from intermittent symptoms
of dizziness, he remained well until August 1978 when he sustained a second acute
myocardial infarction and died. An autopsy was not obtained.
Comment
The diagnosis of SLE was established by the positive LE preparation, low C3
levels, and characteristic renal histopathological findings. Although fever early in his
course was clearly related to a drug-induced hypersensitivity reaction, the onset of
fever six months prior to his death and subsequent neurological manifestations may
have been related to SLE.
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Case 4
M.M., a 23-year-old woman, sought medical attention in 1976 for dependent
edema of three months' duration. Except forevidence ofgeneralized edema, physical
examination was normal. She denied malaise, fever, rash, or arthritis. Laboratory
studies included: urinalysis 4+ protein with normal urinary sediment, urinary protein
excretion 7.0 gm/dl, ANF 1:4, DNA-bc 27 percent, serum albumin 2.6 gm/dl, serum
creatinine 0.8 mg/dl and creatinine clearance was 90 ml/min. A percutaneous renal
biopsy was performed. By light microscopy, there was basement membrane thicken-
ing with focal reduplication. The mesangium was prominent due to focal hyperplasia.
Electronmicroscopy revealed foot process fusion, epimembranous deposits, and a
moderate hyperplastic mesangium with focal sclerosis and mesangial deposits.
Immunofluorescent staining showed granular depositions of IgG and C3 in capillary
walls.
The patient was discharged on diuretic therapy alone. The following year she
became pregnant. The delivery was complicated by hypertension and increased
edema. Laboratory studies included: ANF 1: 128, DNA-bc 13 percent. One month
post partum, she was hospitalized because offever, persistent hypertension, and signs
of congestive heart failure. Physical examination revealed S3 and S4 gallops and
bilateral dullness to percussion with absent breath sounds at the lung bases.
Laboratory tests included: urinalysis 4+ protein, normal urinary sediment, urinary
protein excretion 9.3 gm/day, serum creatinine 0.7 mg/dl, creatinine clearance 130
ml/min, ANF 1:128, LE preparation +, C3 51 mg/dl, C4 11 mg/dl. A 99 M Tc
sodium pertechnetate first pass dynamic heart scan was performed and showed an
ejection fraction of 36 percent (normal value > 55 percent). During the first week of
hospitalization, the patient continued to have temperatures to 103.6°F. The patient
was placed on prednisone, 90 mg/day, which resulted in rapid defervescence. She was
discharged on prednisone, digitalis, and furosemide. She was readmitted several
months later with fever and a right lower lobe infiltrate on chest roentgenogram.
Laboratory studies showed: serum creatinine 0.9 mg/dl, ANF 1:64, DNA-bc 4
percent, C3 98 mg/dl, C4 33 mg/dl. She was treated with antibiotics, recovered
rapidly, and was discharged on the sixth hospital day. Since that time her clinical
condition has remained stable.
Comment
The elevated DNA-bc level and mesangial deposits, in association with epimem-
branous deposits, by renal biopsy, strongly suggested the possibility of SLE in 1976
when this patient was first evaluated for nephrotic syndrome. The diagnosis of SLE
was established subsequently by the positive LE preparation. The fever and cardio-
myopathy which occurred post partum probably represent systemic manifestations
of SLE.
DISCUSSION
The four patients described in this report initially sought medical care because of
generalized edema due to nephrotic syndrome. Except for patient 2, in whom fever
occurred initially, there were no signs or symptoms suggestive of SLE at the time of
initial presentation. During follow-up, however, each of the other three patients
ultimately developed clinical findings frequently associated with the systemic mani-
festations of SLE: Patient 1 had a rash due to a leukocytoclastic angiitis, patient 3
developed a recurrent fever of unknown etiology, and patient 4 had fever and
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erythemia, Raynaud's phenomena, alopecia, photosensitivity, and arthritis, did not
occur in any of these four patients.
The diagnosis of SLE in these cases was established on the basis of serological
studies and renal histopathological findings. In cases 1-3, the finding of a prolifera-
tive glomerulonephritis with electron-dense deposits in subendothelial, subepithelial,
and mesangial loci was considered to be highly suggestive oflupus nephropathy[6,7].
The combination of clinical features and renal histopathology were not compatible
with other entities in which subendothelial deposits are also found, such as post-
infectious glomerulonephritis [8], mesangiocapillary glomerulonephritis [9], and
Henoch-Scholein purpura [10]. The renal biopsy findings in case 4 were also
suggestive of lupus nephropathy because of the association of mesangial and
epimembranous electron-dense deposits. Mesangial deposits have not been de-
scribed, characteristically, in idiopathic membranous nephropathy [6], but are
commonly found in patients with membranous lupus nephropathy [7].
Serological studies were used to confirm the diagnosis of SLE. In each case, an
antinuclear factor was found and either identified as an anti-DNA antibody or
associated with a positive LE preparation. Patient 1 had an elevated ANF titer and
reduced C3 on initial evaluation, and subsequently an elevated DNA-bc. Patient 2
had elevated ANF titer, increased DNA-bc, and reduced C3. Patient 3 had elevated
ANF titer, positive LE preparation, and reduced C3. Patient 4 had elevated DNA-bc
initially, and later a positive LE preparation, elevated ANF titer, and reduced C3. A
DNA-bc level greater than 20 percent was considered highly specific for SLE. Adler
and associates, working in our laboratory, previously reported that levels of DNA-bc
did not exceed 20 percent in normal individuals orpatients with rheumatoid arthritis
or rheumatoid variants [5]. Moreover, except for the report byPincus and associates
[11], other groups have also reported that DNA-bc greater than 20 percent is highly
discriminatory for SLE in untreated patients [12,13,14,15,16,17].
Several reports of large series of patients have stated that lupus nephropathy may
represent the initial clinical manifestation ofSLE in three to six percent ofcases[2,3].
This type of clinical presentation of SLE, however, has not been documented since
data were not included that either demonstrated the diagnosis of SLE or the type of
renal disease at onset of illness. Lupus nephropathy as the sole presenting manifesta-
tion of SLE was also suggested by two recent reports. Libit and associates described
three children, ages 10 to 14 years, with epimembranous nephropathy who developed
clinical and serological evidence of SLE which included the appearance of rash and
multisystem disease one and a half to three and a halfyears after thefirst evidence of
renal disease [18]. In contrast to the cases in the present report, serological studies for
SLE were negative at the time of the initial evaluation. Two similar cases were
reported by Kallen and associates [19], in which the nephrotic syndrome, due to
typical epimembranous nephropathy, developed in the absence of serological evi-
dence of SLE. One and three years later, respectively, both children developed
systemic manifestations and serological evidence of SLE. Re-evaluation, by renal
biopsy, demonstrated a proliferative glomerulonephritis with electron-dense depos-
its in subendothelial and mesangial loci, in addition to epimembranous deposits in
both cases. Although there was no direct evidence that the initial glomerulonephrop-
athy in these previously reported cases was caused by SLE, the authors suggested a
causal relationship since both membranous nephropathy and SLE, as separate
disease entities, are relatively uncommon in children.
The present report documents the occurrence of lupus nephropathy as the sole
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initial manifestation of SLE. It becomes evident, therefore, that under certain
circumstances, the diagnostic criteria established by the ARA may not be sufficiently
inclusive for all cases of SLE. These findings emphasize the importance of consider-
ing the possibility of SLE even in patients with apparent primary renal disease.
Observations made in the present series ofpatients suggest that important clues to the
eventual diagnosis of SLE may be provided by careful assessment of the pattern of
glomerular ultrastructural changes and that confirming evidence can be obtained by
appropriate serological studies.
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